Free Newsletter
Apps merge for trial subject tasks
Perceptive Informatics sees a definite uptick in the need for interoperability among automated clinical trial management applications. It has begun answering that need by enhancing the interoperability of two products in its mainstay eClinical suite: DataLabs and ClinPhone.
DataLabs is an electronic data capture solution, and ClinPhone comprises randomization and trial supply management (RTSM) technologies.
"We're seeing a huge uptake of the combination [of interoperable EDC and RTSM applications], perhaps most significant on the EDC side," says Bill Byrom, senior director for eClinical product strategy, based in Nottingham, U.K. "There's a definite shift to customers who want both."
The enhanced interoperability between DataLabs and ClinPhone comes about via "robust" middleware called the clinical technology integration platform (CTIP), he explains. The middleware allows the passing of data between solutions at the back end, according to a company technical note, allowing the use of either DataLabs or ClinPhone for two of the most common patient-level activities done by investigators: randomizing patients and dispensing medication.
"Those are the ones we focused on first," Byrom says in an interview. Follow-on efforts for enhanced interoperability may target additional patient-level activities, or perhaps site-level activities. "We're looking at the areas of convergence most important to customers," he adds.
- here's the release
- see the company technical article
Related Articles:
CRO opts for standards in EDC
Offerings pit interoperability vs. integration
Supplier focus is interoperability
Comments
Reading your article "Apps merge for trial subject tasks" I have noticed many new information which I have not known before. First of all it was really new for me that DataLabs is an electronic data capture solution, and ClinPhone comprises randomization and trial supply management (RTSM) technologies. I have to admit that I my work is related with technologies but this is not a my sphere... That's why this information is really new for me. I have to admit that it was quite interesting to read a=it and to know something new. Well I will definitely try to find more information about this subject. Thanks a lot for sharing this great post and keep up publishing those great news in the future.
Sincerely, Greg Matton from iphone application development
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




